Moderna to Host Investor Event - Science Day
-
Rubio seeks to strengthen US foothold in Central Asia
-
One year after Louvre heist, where are the missing jewels?
-
LeBron joins 76ers to chase one more NBA title at age 41
-
Knicks face tall task in NBA championship repeat bid
-
Rays one win from World Series return after downing Guardians
-
Warriors' Curry 'fine' after limping out of practice - Kerr
-
Kings' Ben Simmons tears Achilles in training
-
Zelensky speaks to US envoys as Trump lashes out
-
Lula, Bolsonaro set for first debate showdown in bitter election race
-
'Surprise package' Lazio crush Juve to keep pace with Serie A leaders Inter
-
Mbappe hits two as Real Madrid rout Sevilla
-
China growth expected to miss official target in third quarter
-
Browns edge Ravens for division lead, Texans beat Jags
-
Lazio crush Juventus to move level with Serie A leaders Inter
-
Lyon go top of Ligue 1 as Monaco fall to first defeat of the season
-
Leeds draw feels like 'fresh start' for Man Utd's Carrick
-
Venezuela opposition alliance reaffirms Nobel laureate Machado as leader
-
Macron denounces 'unbridled' violence as France hit by new clashes
-
'Street Fighter' wins N. America box office, buzzy doc stuns in 2nd
-
Hurzeler lauds 'hard worker' Gomez after Brighton goal from halfway line
-
NFL: Paris game to go ahead despite protests in France
-
Toulouse hold off Exeter, Northampton save English Champions Cup blushes
-
Arteta hails Arsenal 'finishers' after Madueke fells Forest
-
Arsenal snatch late win to keep pressure on Man City as Man Utd held
-
Trump backs ally Netanyahu ahead of Israel's tight election
-
Arsenal strike late to keep pressure on Man City as Man Utd held
-
Madueke strikes late as below-par Arsenal sink Forest
-
Four soldiers dead, dozens injured in fire at Canada military base
-
Second day of street clashes in Milan
-
Ton-up Agha helps Pakistan down Sri Lanka in tri-series opener
-
Dupont's Toulouse hold off Exeter as English Champions Cup woes continue
-
Man Utd draw at Leeds keeps pressure on Carrick
-
Zelensky speaks to US envoys amid Trump spat
-
Barca defenders Garcia, Kounde injured before key games
-
Paris police in new battles with protesters and looters
-
Lula, Bolsonaro to face off in first debate of bruising election
-
Multiple deaths, injuries at western Canada military base: minister
-
Maza and Schick help Leverkusen clip Freiburg's wings
-
Boland strikes twice for Australia in rain-hit South Africa Test
-
Leeds hit back to deny Man Utd morale-boosting win
-
Marseille put Angers to the sword in Ligue 1
-
Zelensky tells NBC 'thankful' US has unblocked intelligence sharing
-
Albanian PM refuses to quit as violent protests enter sixth day
-
Pau see off Leicester in Champions Cup
-
Chwalinska fights back to win Wuhan Open in title breakthrough
-
Kremlin says Ukrainian attacks won't change war aims as Kyiv hits Saint Petersburg
-
Kulusevski on brink of return for Spurs after 17-month absence
-
Martinez starts for Man Utd after outburst
-
Ukraine sets Saint Petersburg refinery ablaze in large-scale drone attack
-
Alberta separatists rally ahead of independence vote
Moderna to Host Investor Event - Science Day
CAMBRIDGE, MA / ACCESS Newswire / June 17, 2026 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Science Day at 9:00am ET on Thursday, June 25, 2026.
The event will feature an overview of Moderna's research and early development programs, highlighting how the Company's mRNA platform, together with advances in AI and robotics, is accelerating innovation and creating opportunities to expand into new therapeutic areas.
A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.
A replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
M.Thompson--AMWN
